Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Biomedical Advanced Research and Development Authority | FED |
Not provided
Not provided
Not provided
Not provided
The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of predictive ILI detection algorithm and associated alerts on protective behaviors related to ILI and assess the accuracy of a predictive ILI detection algorithm using participant self-reported ILI symptoms and diagnosis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Proactive ILI content & Predictions | Experimental | Participants will receive predictive alerts, reactive content after reporting symptoms or receiving an asymptomatic prediction, and ILI-related health educational content |
|
| No Proactive ILI content & Predictions | Experimental | Participants will receive predictive alerts and reactive content after reporting symptoms or receiving an asymptomatic prediction, but will not receive proactive ILI content |
|
| Proactive ILI content & No Predictions | Experimental | Participants will not receive predictive alerts or reactive content after reporting symptoms but will receive proactive ILI content |
|
| No Proactive ILI content & No Predictions | Experimental | Participants will not receive predictive alerts or reactive content after reporting symptoms or proactive ILI content |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ILI Predictive Alerts, Reactive Content, and Proactive Content | Behavioral | Participants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms, in addition they also receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors. |
| Measure | Description | Time Frame |
|---|---|---|
| The primary objective of this study is to assess the effectiveness of a predictive ILI detection algorithm and associated alerts on ILI-related health and behavioral outcomes | The difference between the predictive alert and the no predictive alert groups in the proportion of cohort members who performed any target health behavior 1-4 (i.e. performed at least one of: reduced spread, tested, sought medical attention, or was treatment adherent) | Through study completion, approximately 10 months |
| Measure | Description | Time Frame |
|---|---|---|
| The secondary objective is to assess the accuracy of an ILI detection algorithm using self-reported symptoms and ILI diagnosis | Evaluate algorithm performance (against labels from self-reported ILI symptoms and/or self-reported positive diagnosis) overall and per model deployed. Algorithm performance will be assessed across a variety of dimensions including ROC AUC, sensitivity, specificity, PPV, and NPV |
| Measure | Description | Time Frame |
|---|---|---|
| The exploratory objective is to assess differences in effectiveness between the four groups on ILI-related health and behavioral outcomes | The difference between all groups in the proportion of cohort members who performed any target health behavior 1-4 (i.e. performed at least one of: reduced spread, tested, sought medical attention, or was treatment adherent) | Through study completion, approximately 10 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ernesto H.N. Ramirez, PhD | Evidation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Evidation Health | San Mateo | California | 94402 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36890264 | Background | Wiemken TL, Khan F, Puzniak L, Yang W, Simmering J, Polgreen P, Nguyen JL, Jodar L, McLaughlin JM. Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Sci Rep. 2023 Mar 8;13(1):3886. doi: 10.1038/s41598-023-31057-1. | |
| 29206909 | Background | Tokars JI, Olsen SJ, Reed C. Seasonal Incidence of Symptomatic Influenza in the United States. Clin Infect Dis. 2018 May 2;66(10):1511-1518. doi: 10.1093/cid/cix1060. |
| Label | URL |
|---|---|
| Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD). Past Seasons Estimated Influenza Disease Burden | View source |
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Feb 8, 2024 | Feb 15, 2024 |
Not provided
Not provided
Not provided
Not provided
Participants will be blinded to their study participation status, participants will not be asked to take any action to enroll in the study.
|
| ILI Predictive Alerts, Reactive Content | Behavioral | Participants receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors. |
|
| Proactive Content | Behavioral | Participants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms. |
|
| No Intervention | Behavioral | Participants will not receive predictive alerts or reactive content after reporting symptoms or proactive IILI-related health educational content |
|
| Through study completion, approximately 10 months |
| 35759279 | Background | Temple DS, Hegarty-Craver M, Furberg RD, Preble EA, Bergstrom E, Gardener Z, Dayananda P, Taylor L, Lemm NM, Papargyris L, McClain MT, Nicholson BP, Bowie A, Miggs M, Petzold E, Woods CW, Chiu C, Gilchrist KH. Wearable Sensor-Based Detection of Influenza in Presymptomatic and Asymptomatic Individuals. J Infect Dis. 2023 Apr 12;227(7):864-872. doi: 10.1093/infdis/jiac262. |
| 35552722 | Background | Mezlini A, Shapiro A, Daza EJ, Caddigan E, Ramirez E, Althoff T, Foschini L. Estimating the Burden of Influenza-like Illness on Daily Activity at the Population Scale Using Commercial Wearable Sensors. JAMA Netw Open. 2022 May 2;5(5):e2211958. doi: 10.1001/jamanetworkopen.2022.11958. |
| 33506230 | Background | Shapiro A, Marinsek N, Clay I, Bradshaw B, Ramirez E, Min J, Trister A, Wang Y, Althoff T, Foschini L. Characterizing COVID-19 and Influenza Illnesses in the Real World via Person-Generated Health Data. Patterns (N Y). 2020 Dec 13;2(1):100188. doi: 10.1016/j.patter.2020.100188. eCollection 2021 Jan 8. |
| 36951890 | Background | Hunter V, Shapiro A, Chawla D, Drawnel F, Ramirez E, Phillips E, Tadesse-Bell S, Foschini L, Ukachukwu V. Characterization of Influenza-Like Illness Burden Using Commercial Wearable Sensor Data and Patient-Reported Outcomes: Mixed Methods Cohort Study. J Med Internet Res. 2023 Mar 23;25:e41050. doi: 10.2196/41050. |
| Background | Merrill MA, Safranchik E, Kolbeinsson A, Gade P, Ramirez E, Schmidt L, Foshchini L, Althoff T. Homekit2020: A benchmark for time series classification on a large mobile sensing dataset with laboratory tested ground truth of influenza infections. Proceedings of Machine Learning Research LEAVE UNSET:1-22, 2023. |
| 35480626 | Background | Mayer C, Tyler J, Fang Y, Flora C, Frank E, Tewari M, Choi SW, Sen S, Forger DB. Consumer-grade wearables identify changes in multiple physiological systems during COVID-19 disease progression. Cell Rep Med. 2022 Apr 19;3(4):100601. doi: 10.1016/j.xcrm.2022.100601. eCollection 2022 Apr 19. |
| 36963907 | Background | Nestor B, Hunter J, Kainkaryam R, Drysdale E, Inglis JB, Shapiro A, Nagaraj S, Ghassemi M, Foschini L, Goldenberg A. Machine learning COVID-19 detection from wearables. Lancet Digit Health. 2023 Apr;5(4):e182-e184. doi: 10.1016/S2589-7500(23)00045-6. No abstract available. |
| Background | Rosenstock, I. M. (2000). Health Belief Model. In A. E. Kazdin (Ed.), Encyclopedia of psychology (Vol. 4, pp. 78-80). Oxford University Press. |
| 35898953 | Background | Zewdie A, Mose A, Sahle T, Bedewi J, Gashu M, Kebede N, Yimer A. The health belief model's ability to predict COVID-19 preventive behavior: A systematic review. SAGE Open Med. 2022 Jul 22;10:20503121221113668. doi: 10.1177/20503121221113668. eCollection 2022. |
| 33431259 | Background | Mercadante AR, Law AV. Will they, or Won't they? Examining patients' vaccine intention for flu and COVID-19 using the Health Belief Model. Res Social Adm Pharm. 2021 Sep;17(9):1596-1605. doi: 10.1016/j.sapharm.2020.12.012. Epub 2020 Dec 30. |
| 36165548 | Background | Gutierrez F, Wolfe J. Using the Health Belief Model to improve influenza vaccination rates. JAAPA. 2022 Oct 1;35(10):46-47. doi: 10.1097/01.JAA.0000873832.52485.65. |
| 37747766 | Background | Richardson KM, Jospe MR, Saleh AA, Clarke TN, Bedoya AR, Behrens N, Marano K, Cigan L, Liao Y, Scott ER, Guo JS, Aguinaga A, Schembre SM. Use of Biological Feedback as a Health Behavior Change Technique in Adults: Scoping Review. J Med Internet Res. 2023 Sep 25;25:e44359. doi: 10.2196/44359. |
| 24275499 | Background | McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014 Mar;67(3):267-77. doi: 10.1016/j.jclinepi.2013.08.015. Epub 2013 Nov 22. |
| 27748683 | Background | Mansournia MA, Higgins JP, Sterne JA, Hernan MA. Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology. 2017 Jan;28(1):54-59. doi: 10.1097/EDE.0000000000000564. |
| 31647125 | Background | LaFave SE, Granbom M, Cudjoe TKM, Gottsch A, Shorb G, Szanton SL. Attention control group activities and perceived benefit in a trial of a behavioral intervention for older adults. Res Nurs Health. 2019 Dec;42(6):476-482. doi: 10.1002/nur.21992. Epub 2019 Oct 24. |
| 34535755 | Background | Lee JL, Foschini L, Kumar S, Juusola J, Liska J, Mercer M, Tai C, Buzzetti R, Clement M, Cos X, Ji L, Kanumilli N, Kerr D, Montanya E, Muller-Wieland D, Ostenson CG, Skolnik N, Woo V, Burlet N, Greenberg M, Samson SI. Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial. NPJ Digit Med. 2021 Sep 17;4(1):138. doi: 10.1038/s41746-021-00508-2. |
| Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD). Past Seasons Estimated Influenza Disease Burden | View source |
| Centers for Disease Control and Prevention. COVID Data Tracker. | View source |
| Centers for Disease Control and Prevention, Office of Public Health Data, Surveillance, and Technology. 2023. RESP-NET Interactive Dashboard. | View source |
| ICF_001.pdf |
| ID | Term |
|---|---|
| D007251 | Influenza, Human |
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D009976 | Orthomyxoviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012140 | Respiratory Tract Diseases |
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D008171 | Lung Diseases |
Not provided
Not provided